Transphorm, Inc (TGAN) Tops Q2 EPS by 7c

Transphorm, Inc (OTC: TGAN) reported Q2 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $11.3 million versus the consensus estimate of $11.63 million.

For earnings history and earnings-related data on Transphorm, Inc (TGAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c